Literature DB >> 1430152

Cytokines in neuroinflammatory disease: role of myelin autoreactive T cell production of interferon-gamma.

T Olsson1.   

Abstract

Many cytokines must be considered as effector and immunoregulatory molecules in neuroinflammatory diseases such as multiple sclerosis (MS) and experimental allergic encephalomyelitis (EAE). We have studied the potential role of interferon-gamma (IFN-gamma) in the pathogenesis of these diseases, since this cytokine has a number of important effects such as macrophage activation, induction of MHC class I and class I antigens, and T cell homing. An immunospot assay that allows enumeration of single cells secreting IFN-gamma after short-term culture in vitro of mononuclear cell suspensions has been used. In EAE, increased numbers of IFN-gamma-secreting cells (IFN-gamma-sc) appear in the central nervous system shortly before onset of clinical signs. Such cells also increased during pharmacologically induced relapse of EAE. In later stages of EAE, memory T cells that produced IFN-gamma in response to presented antigen, recognized multiple regions of the myelin basic protein (MBP), showing that (i) myelin autoreactive T cells have the functional ability to produce this cytokine, (ii) the concept of immunodominance as to autoantigen peptide reactivity is non-absolute and time-dependent. In multiple sclerosis (MS) there are increased numbers of IFN-gamma-sc among the CSF cells. Also, there are increased numbers of memory T cells, strongly enriched to the cerebrospinal fluid, which upon recognition of several myelin antigens and several MBP peptide stretches, produce IFN-gamma. Taken together, the data are consistent with a role for IFN-gamma as a key mediator in inflammatory demyelinating diseases.

Entities:  

Mesh:

Substances:

Year:  1992        PMID: 1430152     DOI: 10.1016/0165-5728(92)90135-8

Source DB:  PubMed          Journal:  J Neuroimmunol        ISSN: 0165-5728            Impact factor:   3.478


  41 in total

Review 1.  Janus-like effects of type I interferon in autoimmune diseases.

Authors:  Robert C Axtell; Chander Raman
Journal:  Immunol Rev       Date:  2012-07       Impact factor: 12.988

2.  Correlation between interferon production and clinical disease activity in patients with multiple sclerosis.

Authors:  M Dettke; P Scheidt; H Prange; H Kirchner
Journal:  J Clin Immunol       Date:  1997-07       Impact factor: 8.317

3.  T-cell properties determine disease site, clinical presentation, and cellular pathology of experimental autoimmune encephalomyelitis.

Authors:  Sara Abromson-Leeman; Rod Bronson; Yi Luo; Michael Berman; Rebecca Leeman; Joshua Leeman; Martin Dorf
Journal:  Am J Pathol       Date:  2004-11       Impact factor: 4.307

4.  Induction and blockage of oligodendrogenesis by differently activated microglia in an animal model of multiple sclerosis.

Authors:  Oleg Butovsky; Gennady Landa; Gilad Kunis; Yaniv Ziv; Hila Avidan; Nadav Greenberg; Adi Schwartz; Igor Smirnov; Ayala Pollack; Steffen Jung; Michal Schwartz
Journal:  J Clin Invest       Date:  2006-03-23       Impact factor: 14.808

Review 5.  Science gone translational: the OX40 agonist story.

Authors:  Andrew D Weinberg; Nicholas P Morris; Magdalena Kovacsovics-Bankowski; Walter J Urba; Brendan D Curti
Journal:  Immunol Rev       Date:  2011-11       Impact factor: 12.988

6.  Adoptive transfer of experimental allergic neuritis in the immune suppressed host.

Authors:  A F Hahn; T E Feasby; D Lovgren; L Wilkie
Journal:  Acta Neuropathol       Date:  1993       Impact factor: 17.088

Review 7.  Mechanisms of action of interferon-beta in multiple sclerosis.

Authors:  B G Arnason; A Dayal; Z X Qu; M A Jensen; K Genç; A T Reder
Journal:  Springer Semin Immunopathol       Date:  1996

Review 8.  T cell subsets and their signature cytokines in autoimmune and inflammatory diseases.

Authors:  Itay Raphael; Saisha Nalawade; Todd N Eagar; Thomas G Forsthuber
Journal:  Cytokine       Date:  2014-10-30       Impact factor: 3.861

9.  Autoreactive Tbet-positive CD4 T cells develop independent of classic Th1 cytokine signaling during experimental autoimmune encephalomyelitis.

Authors:  Wen-I Yeh; Ian L McWilliams; Laurie E Harrington
Journal:  J Immunol       Date:  2011-10-07       Impact factor: 5.422

Review 10.  Oligodendroglial response to the immune cytokine interferon gamma.

Authors:  B Popko; K D Baerwald
Journal:  Neurochem Res       Date:  1999-02       Impact factor: 3.996

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.